• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.

作者信息

Jin Liping, Le Jiayuan, Sun Yuming, Zeng Furong

机构信息

Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, China.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2380568. doi: 10.1080/21645515.2024.2380568. Epub 2024 Sep 5.

DOI:10.1080/21645515.2024.2380568
PMID:39235465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11385444/
Abstract
摘要

相似文献

1
Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.对《COVID-19 全程接种 ZF2001 住院患者的临床特征及危险因素：一项回顾性队列研究》评论的回应
Hum Vaccin Immunother. 2024 Dec 31;20(1):2380568. doi: 10.1080/21645515.2024.2380568. Epub 2024 Sep 5.
2
Letter to the editor to 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.致编辑的信：“新冠病毒病（COVID-19）完全接种ZF2001疫苗住院患者的临床特征及危险因素：一项回顾性队列研究”
Hum Vaccin Immunother. 2024 Dec 31;20(1):2380566. doi: 10.1080/21645515.2024.2380566. Epub 2024 Aug 20.
3
Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study.COVID-19 住院患者接种 ZF2001 后的临床特征和危险因素：一项回顾性队列研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2355683. doi: 10.1080/21645515.2024.2355683. Epub 2024 Jun 11.
4
Repeated-dose toxicity and immunogenicity evaluation of a recombinant subunit COVID-19 vaccine (ZF2001) in rats.重组亚单位新冠病毒疫苗（ZF2001）在大鼠中的重复给药毒性和免疫原性评价
Front Cell Infect Microbiol. 2025 Apr 22;15:1548787. doi: 10.3389/fcimb.2025.1548787. eCollection 2025.
5
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.一种基于重组串联重复二聚体 RBD 的蛋白亚单位疫苗（ZF2001）在成年人中的安全性和免疫原性：两项随机、双盲、安慰剂对照、1 期和 2 期临床试验。
Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24.
6
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.一种基于鼻腔内的 OMV 疫苗可诱导针对 SARS-CoV-2 感染的高黏膜和全身保护免疫。
Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021.
7
Why Oxford's positive COVID vaccine results are puzzling scientists.为何牛津大学新冠疫苗的阳性结果令科学家们感到困惑。
Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.
8
Could mixing COVID vaccines boost immune response?混合接种新冠疫苗能增强免疫反应吗？
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
9
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.奥密克戎变异株对疫苗加强后免疫血清的中和敏感性低于其他 SARS-CoV-2 变异株。
Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440.
10
COVID-19 vaccination and treatment in vulnerable populations.弱势群体中的新冠病毒疫苗接种与治疗
Immunology. 2022 Feb;165(2):141-142. doi: 10.1111/imm.13445.

本文引用的文献

1
Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study.COVID-19 住院患者接种 ZF2001 后的临床特征和危险因素：一项回顾性队列研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2355683. doi: 10.1080/21645515.2024.2355683. Epub 2024 Jun 11.
2
N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study.快速侧向流试验检测 N 抗原血症可预测 COVID-19 患者 90 天死亡率：一项前瞻性队列研究。
Clin Microbiol Infect. 2022 Oct;28(10):1391.e1-1391.e5. doi: 10.1016/j.cmi.2022.05.023. Epub 2022 May 30.
3
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.西班牙老年 COVID-19 患者队列中托珠单抗和皮质类固醇的预后因素及联合应用。
J Med Virol. 2022 Apr;94(4):1540-1549. doi: 10.1002/jmv.27488. Epub 2021 Dec 7.
4
Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes.建立多变量预测模型的最小样本量：第二部分 - 二分类和生存数据。
Stat Med. 2019 Mar 30;38(7):1276-1296. doi: 10.1002/sim.7992. Epub 2018 Oct 24.